| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/11/2006 | US7026443 Composition including an oligopeptide 13 residues or less in length, which comprises the sequence ATLERTEVY (SEQ ID NO:31040); use in epitope-based vaccines |
| 04/11/2006 | US7026294 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 04/11/2006 | US7026289 Method and compositions for treating hyperlipidemia and other conditions |
| 04/11/2006 | US7026282 including units from amino acids with cyclopentyl, cyclohexyl, cycloheptyl or decahydronaphthalenyl rings; inhibitors of the binding interaction between human urokinase plasminogen activator and its cell surface receptor; treatment of cancer |
| 04/11/2006 | US7026280 Polypeptides; nervous system, brain disorders |
| 04/11/2006 | US7026129 IG lambda biopolymer markers predictive of Alzheimers disease |
| 04/11/2006 | US7025964 Peptide-based immunotherapeutic agent |
| 04/11/2006 | CA2358829C Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/06/2006 | WO2006035681A1 HLA-A11-RESTRICTED Tax ANTITUMOR EPITOPES |
| 04/06/2006 | WO2006035595A1 Molecular orbit computing device for elongation method |
| 04/06/2006 | WO2005051799A3 Peptide increasing fusiogenic capacity of a gamete |
| 04/06/2006 | US20060074015 Enhanced immunosuppressive activity; treatment of ocular allergy, dry eye, and autoimmune and chronic inflammatory diseases, such as asthma, rheumatoid arthritis, multiple sclerosis, psoriasis, and ulcerative colitis |
| 04/06/2006 | US20060073575 Methods and reagents for assaying protein kinase activity |
| 04/06/2006 | US20060073529 Luciferyl peptide substrate |
| 04/06/2006 | US20060073522 Derived from ghrelin polypeptide, labelled with fluorochrome and cysteine; drug screening; high throughput assay |
| 04/06/2006 | US20060073518 Method for selecting a candidate drug compound |
| 04/06/2006 | US20060073517 Post-translational modifications of proteins as regulatory switches |
| 04/06/2006 | US20060073114 Compounds and methods to inhibit or augment an inflammatory response |
| 04/05/2006 | EP1558644A4 A structured peptide scaffold for displaying turn libraries on phage |
| 04/05/2006 | EP1488011A4 Method of isolating binding peptides from a combinatorial phage display library and peptides produced thereby |
| 04/05/2006 | EP1147413B1 Growth differentiation factor inhibitors and uses therefor |
| 04/05/2006 | EP1102785A4 COMPOSITIONS AND METHODS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES |
| 04/05/2006 | EP0991660B8 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS |
| 04/05/2006 | EP0772773B1 Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME |
| 04/05/2006 | CN1756765A Metastin derivatives and their use |
| 04/05/2006 | CN1756763A Dimerized peptide |
| 04/05/2006 | CN1249086C Melanocortin receptor ligands |
| 04/05/2006 | CN1249081C Glycopeptide derivatives and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249079C Process for partitioning of proteins |
| 04/05/2006 | CN1248739C Method for identifying individuals suffering from cellular abnormality |
| 04/05/2006 | CN1248732C Embonate medicine composition containing bombesin-like product |
| 04/05/2006 | CN1248671C Use of 3-position cyclosporin derivatives for hair growth |
| 04/04/2006 | US7022815 truncated derivatives of PTH; have one of the following key substitutions: Ser3 --> Ala, Asn10 --> Ala or Gln; Leu11 --> Arg, Gly12 --> Ala and His14 --> Trp; use to treat bone disorders such as osteoporosis |
| 04/04/2006 | US7022675 Administering angiotensin ii |
| 04/04/2006 | US7022669 such as 1-[4-[[(1H-benzimidazol-2-yl)-methyl]-amino]-N2-[[4'-(pentyloxy) [1,1':4', 1'' terphenyl]-4-yl]-carbonyl]-L-ornithine]-4-[4-(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandin B trifluoroacetate |
| 03/30/2006 | WO2006034134A2 Antibacterial peptide with activity against b. anthracis |
| 03/30/2006 | WO2006032923A2 Inhibitors of protein kinase a anchoring |
| 03/30/2006 | WO2006032457A1 Peptide cyclisation |
| 03/30/2006 | WO2005098435A3 Peptides and peptidomimetics binding to cd23 |
| 03/30/2006 | WO2005090995A3 Method for the detection of autoantibodies against specific peptides and its use in diagnosis and treatment of pregnancy-loss or infertility |
| 03/30/2006 | US20060069238 Synthetic glyco-lipo-peptides as vaccines |
| 03/30/2006 | US20060069030 Apolipoprotein A1 mimetics and uses thereof |
| 03/30/2006 | US20060069027 Inhibitors of hepatitis C virus |
| 03/30/2006 | US20060069017 Somatostatin analog and uses thereof |
| 03/30/2006 | US20060069016 Immunosupressant carbon-carbon triple bond on the side chain of the position one amino acid : ocular allergy, dry eye, autoimmune and chronic inflammatory diseases, asthma, rheumatoid arthritis, multiple sclerosis, psoriasis, ulcerative colitis |
| 03/30/2006 | US20060069015 Immunosuppressive agent; novel cyclosporin derivatives chemically modified from cyclosporin A; chemically modified side chain at the position one amino acid and optionally a substitution at the position three amino acid of cyclosporin A; ocular allergy, dry eye, autoimmune, chronic inflammatory diseases |
| 03/30/2006 | US20060068505 Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons |
| 03/30/2006 | US20060068470 Antifreeze proteins from basidiomy cetes |
| 03/30/2006 | US20060068457 Substrates for tafi (a) |
| 03/30/2006 | US20060067932 Antagonists specific for denatured collagen and methods of using same |
| 03/30/2006 | US20060067929 Administering a modified Clostridial toxin with a proteolytic domain; a translocation domain and an orphanin targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction. |
| 03/30/2006 | DE19911771B4 LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung LHRH antagonist, process for its preparation and its use |
| 03/30/2006 | CA2581215A1 Peptide cyclisation |
| 03/30/2006 | CA2579905A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp |
| 03/29/2006 | EP1639509A2 Protein crystal comprising the processivity clamp factor of dna polymerase and a ligand, and its uses |
| 03/29/2006 | EP1638991A2 Cosmetic or dermopharmaceutical composition for reducing the signs of cutaneous ageing |
| 03/29/2006 | EP1638557A2 Glycogen synthase kinase-3 inhibitors |
| 03/29/2006 | EP1268850B1 Fluorescence detection of proteases or peptidases |
| 03/29/2006 | EP1064300A4 Peptide turn mimetics |
| 03/29/2006 | EP1036090B1 Echinocandin derivatives, preparation method and application as anti-fungal agents |
| 03/29/2006 | CN1752099A SARS-S antigen polypeptide capable of inducing producing specificity immune response |
| 03/29/2006 | CN1247541C Cyclic imines as pesticides |
| 03/29/2006 | CN1247254C Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 03/29/2006 | CN1247183C Dental products comprising bone growth enhancing peptide |
| 03/28/2006 | USRE39048 substitution of the sixth amino acid Glycine of the LHRH (luteinizing hormone releasing hormone) decapeptide by D-Lysine or D-Glutamine; the resulting variant peptide is coupled to a common carrier and/or mild adjuvant; immunocastration; mammals |
| 03/28/2006 | US7019118 Antiinflammatory agents; rheumatic disease |
| 03/28/2006 | US7019112 Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses therefor |
| 03/28/2006 | US7019110 Streptogramin derivatives, preparation method and compositions containing same |
| 03/28/2006 | US7019109 SSTR1-selective analogs |
| 03/28/2006 | US7019108 Especially the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini. |
| 03/28/2006 | US7018996 Bactericides, antiseptic; Streptomyces culture; peptide antibiotics |
| 03/28/2006 | US7018981 Gastrointestinal disorders |
| 03/28/2006 | US7018839 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator |
| 03/23/2006 | WO2006031885A2 Kdr and vegf/kdr binding peptides |
| 03/23/2006 | WO2006031226A1 Region of factor ixa protease domain that interacts with factor viiia and methods therefor |
| 03/23/2006 | WO2006031117A1 Lipoxygenase inhibitor peptides and their use |
| 03/23/2006 | WO2006030840A1 Process for synthesis of mucin-type peptides and muc1-related glycopeptides |
| 03/23/2006 | WO2006030770A1 Hla-binding peptide, dna fragment encoding the same and recombinant vector |
| 03/23/2006 | WO2006030722A1 Amino acid sequence essential to neurospecific gene expression |
| 03/23/2006 | WO2006029459A1 Antibodies specific for hepatocellular carcinoma and other carcinomas and uses thereof |
| 03/23/2006 | WO2006020748A2 Gfp-snap25 fluorescence release assay for botulinum toxin protease activity |
| 03/23/2006 | WO2005121354A3 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof |
| 03/23/2006 | WO2005116643A3 Identification of compounds modifying a cellular response |
| 03/23/2006 | WO2005071095A3 Fluorogenic kinase assays and substrates for kinases and phosphatases |
| 03/23/2006 | US20060064252 Small molecule mimetics of erythropoietin |
| 03/23/2006 | US20060063918 Process for rapid solution synthesis of peptides |
| 03/23/2006 | US20060063917 Monospecificity quality of the peptide ligands specific for AcNPV DBP; post-translational modifications are similar to those found in mammalian cells; vectors for the expression of foreign genes and pest control |
| 03/23/2006 | US20060063807 Low molecular weight peptidomimetic growth hormone secretagogues |
| 03/23/2006 | US20060063717 Novel inhibitor of beta amyloid cleavage |
| 03/23/2006 | US20060063701 synthetic polypeptides capable of binding complement component C5a anaphylatoxin and inhibiting complement component C5a activity; antiinflammatory agents |
| 03/23/2006 | US20060063699 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 03/23/2006 | US20060063172 Method for detection of the presence or absence of methylthioadenosine phosphorylase (MTAse) in a cell sample by detection of the presence or absence of MTAse encoding nucleic acid in the cell sample |
| 03/23/2006 | US20060062805 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
| 03/23/2006 | US20060062761 Modified interferon alpha with reduced immunogenicity |
| 03/23/2006 | DE4007605B4 SDK-Peptide, Verfahren zu ihrer Herstellung und diese enthaltende therapeutischen Zusammensetzungen SDK peptides, process for their preparation and therapeutic compositions containing |
| 03/23/2006 | DE10344561A1 Use of proteins and peptides from royal jelly, as antibacterial, fungicidal and antiviral agents, where activity is associated with short amino acid sequences |
| 03/23/2006 | CA2580261A1 Treatment of atherosclerosis |
| 03/23/2006 | CA2576354A1 Gfp-snap25 fluorescence release assay for botulinum toxin protease activity |
| 03/22/2006 | EP1636561A2 Combinatorial protein library screening by periplasmic expression |
| 03/22/2006 | EP1636257A2 Peptides enhancing ceh activity or acat inhibitory activity, pharmaceutical compositions comrising these peptides and their use in the treatment of atherosclerosis |